or Try an Advanced Search...

    Technical Analysis for JSPR - Jasper Therapeutics, Inc

    Grade Last Price % Change Price Change
    D 23.02 0.77% 0.18
    JSPR closed up 0.77 percent on Friday, May 17, 2024, on 78 percent of normal volume.
    Earnings due: Jun 6
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Up
    Historical JSPR trend table...
    Date Alert Name Type % Chg
    Bollinger Band Squeeze Range Contraction 0.00%
    Up 3 Days in a Row Strength 0.00%
    Up 4 Days in a Row Strength 0.00%
    Crossed Above 20 DMA Bullish 0.77%
    MACD Bullish Signal Line Cross Bullish 0.77%
    Bollinger Band Squeeze Range Contraction 0.77%
    Up 3 Days in a Row Strength 0.77%
    Oversold Stochastic Weakness 0.77%
    Stochastic Buy Signal Bullish 6.57%
    Bollinger Band Squeeze Range Contraction 6.57%
    Older End-of-Day Signals for JSPR ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High 3 days ago
    Down 1% 3 days ago
    Up 2% 3 days ago
    Up 1% 3 days ago
    Rose Above 20 DMA 4 days ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    JSPR Chart by TradingView
    Basic chart:

    Profile

    Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. The company develops JSP191, a humanized monoclonal antibody for clearing hematopoietic stem cells from bone marrow in patients undergoing a hematopoietic cell transplantation. It also develops Jasper eHSC Platform to overcome key limitations of allogeneic and autologous gene-edited stem cell grafts. The company is based in Redwood City, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Life Sciences Biology Stem Cell Gene Therapy Transplantation Bone Marrow Hematopoietic Stem Cell

    Is JSPR a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 13 Jasper Therapeutics Announces Briquilimab Development Program in Asthma
    May 7 Jasper Therapeutics to Present at Upcoming Investor Conferences in May
    Mar 28 RBC starts Jasper Therapeutics at outperform, cites market opportunity
    Mar 21 Jasper Therapeutics to Participate in the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference
    Mar 19 Jasper Therapeutics Announces First Patient Dosed in Phase 1b/2a SPOTLIGHT Clinical Study of Briquilimab in Chronic Inducible Urticaria
    Mar 15 New Positive Data Presented on Briquilimab Conditioning in Patients with Fanconi Anemia
    Mar 4 Jasper Therapeutics GAAP EPS of -$1.50 beats by $0.20
    Mar 4 Jasper Therapeutics Reports Fiscal 2023 Financial Results and Recent Corporate Developments
    Feb 26 Jasper Therapeutics to Present at the 43rd Annual TD Cowen Healthcare Conference
    Feb 23 Jasper Therapeutics Presents Data from Preclinical Briquilimab Studies at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting
    See more JSPR news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 31.01
    52 Week Low 4.0
    Average Volume 83,925
    200-Day Moving Average 14.03
    50-Day Moving Average 25.09
    20-Day Moving Average 22.24
    10-Day Moving Average 21.83
    Average True Range 1.74
    RSI (14) 50.25
    ADX 19.03
    +DI 21.01
    -DI 21.06
    Chandelier Exit (Long, 3 ATRs) 20.96
    Chandelier Exit (Short, 3 ATRs) 25.37
    Upper Bollinger Bands 24.56
    Lower Bollinger Band 19.92
    Percent B (%b) 0.67
    BandWidth 20.87
    MACD Line -0.70
    MACD Signal Line -0.84
    MACD Histogram 0.1365
    Fundamentals Value
    Market Cap 346.62 Million
    Num Shares 15.1 Million
    EPS -8.30
    Price-to-Earnings (P/E) Ratio -2.77
    Price-to-Sales 0.00
    Price-to-Book 2.78
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 24.69
    Resistance 3 (R3) 24.73 24.21 24.41
    Resistance 2 (R2) 24.21 23.79 24.19 24.32
    Resistance 1 (R1) 23.62 23.52 23.92 23.58 24.23
    Pivot Point 23.10 23.10 23.25 23.08 23.10
    Support 1 (S1) 22.50 22.67 22.80 22.46 21.81
    Support 2 (S2) 21.98 22.41 21.96 21.72
    Support 3 (S3) 21.39 21.98 21.63
    Support 4 (S4) 21.35